vs
Apellis Pharmaceuticals, Inc.(APLS)与DAKTRONICS INC(DAKT)财务数据对比。点击上方公司名可切换其他公司
DAKTRONICS INC的季度营收约是Apellis Pharmaceuticals, Inc.的1.1倍($229.3M vs $199.9M),DAKTRONICS INC净利率更高(7.6% vs -29.5%,领先37.1%),DAKTRONICS INC同比增速更快(10.0% vs -5.9%),DAKTRONICS INC自由现金流更多($14.0M vs $-14.3M),过去两年DAKTRONICS INC的营收复合增速更高(16.0% vs 7.7%)
Apellis Pharmaceuticals是一家临床阶段生物制药企业,专注于开发调节补体系统的靶向疗法,适应症覆盖年龄相关性黄斑变性继发地图样萎缩等眼科疾病、罕见血液病及自身免疫性疾病,核心市场为美国及欧盟地区。
达科电子是一家总部位于美国南达科他州布鲁金斯的企业,由两名南达科他州立大学教授于1968年创立,主营业务涵盖视频显示屏、记分牌、数字广告牌、动态信息标识、音响系统及相关产品的设计、生产、销售与服务。
APLS vs DAKT — 直观对比
营收规模更大
DAKT
是对方的1.1倍
$199.9M
营收增速更快
DAKT
高出16.0%
-5.9%
净利率更高
DAKT
高出37.1%
-29.5%
自由现金流更多
DAKT
多$28.3M
$-14.3M
两年增速更快
DAKT
近两年复合增速
7.7%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $199.9M | $229.3M |
| 净利润 | $-59.0M | $17.5M |
| 毛利率 | — | 27.0% |
| 营业利润率 | -25.6% | 9.4% |
| 净利率 | -29.5% | 7.6% |
| 营收同比 | -5.9% | 10.0% |
| 净利润同比 | -62.2% | -18.3% |
| 每股收益(稀释后) | $-0.40 | $0.35 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
APLS
DAKT
| Q4 25 | $199.9M | $229.3M | ||
| Q3 25 | $458.6M | $219.0M | ||
| Q2 25 | $178.5M | $172.6M | ||
| Q1 25 | $166.8M | $149.5M | ||
| Q4 24 | $212.5M | $208.3M | ||
| Q3 24 | $196.8M | $226.1M | ||
| Q2 24 | $199.7M | $215.9M | ||
| Q1 24 | $172.3M | $170.3M |
净利润
APLS
DAKT
| Q4 25 | $-59.0M | $17.5M | ||
| Q3 25 | $215.7M | $16.5M | ||
| Q2 25 | $-42.2M | $-9.4M | ||
| Q1 25 | $-92.2M | $-17.2M | ||
| Q4 24 | $-36.4M | $21.4M | ||
| Q3 24 | $-57.4M | $-4.9M | ||
| Q2 24 | $-37.7M | $2.5M | ||
| Q1 24 | $-66.4M | $10.7M |
毛利率
APLS
DAKT
| Q4 25 | — | 27.0% | ||
| Q3 25 | — | 29.7% | ||
| Q2 25 | — | 25.0% | ||
| Q1 25 | — | 24.6% | ||
| Q4 24 | — | 26.8% | ||
| Q3 24 | — | 26.4% | ||
| Q2 24 | — | 25.7% | ||
| Q1 24 | — | 24.5% |
营业利润率
APLS
DAKT
| Q4 25 | -25.6% | 9.4% | ||
| Q3 25 | 48.7% | 10.6% | ||
| Q2 25 | -18.6% | -1.0% | ||
| Q1 25 | -50.0% | -2.4% | ||
| Q4 24 | -12.3% | 7.6% | ||
| Q3 24 | -24.0% | 10.0% | ||
| Q2 24 | -14.7% | 9.0% | ||
| Q1 24 | -36.0% | 4.7% |
净利率
APLS
DAKT
| Q4 25 | -29.5% | 7.6% | ||
| Q3 25 | 47.0% | 7.5% | ||
| Q2 25 | -23.6% | -5.5% | ||
| Q1 25 | -55.3% | -11.5% | ||
| Q4 24 | -17.1% | 10.3% | ||
| Q3 24 | -29.2% | -2.2% | ||
| Q2 24 | -18.9% | 1.2% | ||
| Q1 24 | -38.5% | 6.3% |
每股收益(稀释后)
APLS
DAKT
| Q4 25 | $-0.40 | $0.35 | ||
| Q3 25 | $1.67 | $0.33 | ||
| Q2 25 | $-0.33 | $0.04 | ||
| Q1 25 | $-0.74 | $-0.36 | ||
| Q4 24 | $-0.30 | $0.22 | ||
| Q3 24 | $-0.46 | $-0.11 | ||
| Q2 24 | $-0.30 | $0.18 | ||
| Q1 24 | $-0.54 | $0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $466.2M | $149.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $370.1M | $297.5M |
| 总资产 | $1.1B | $548.4M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
APLS
DAKT
| Q4 25 | $466.2M | $149.6M | ||
| Q3 25 | $479.2M | $136.9M | ||
| Q2 25 | $370.0M | $127.5M | ||
| Q1 25 | $358.4M | $132.2M | ||
| Q4 24 | $411.3M | $134.4M | ||
| Q3 24 | $396.9M | $96.8M | ||
| Q2 24 | $360.1M | $81.3M | ||
| Q1 24 | $325.9M | $76.8M |
总债务
APLS
DAKT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $93.1M | — |
股东权益
APLS
DAKT
| Q4 25 | $370.1M | $297.5M | ||
| Q3 25 | $401.2M | $279.8M | ||
| Q2 25 | $156.3M | $271.9M | ||
| Q1 25 | $164.2M | $272.3M | ||
| Q4 24 | $228.5M | $260.9M | ||
| Q3 24 | $237.1M | $238.2M | ||
| Q2 24 | $264.3M | $238.8M | ||
| Q1 24 | $266.7M | $236.2M |
总资产
APLS
DAKT
| Q4 25 | $1.1B | $548.4M | ||
| Q3 25 | $1.1B | $545.6M | ||
| Q2 25 | $821.4M | $502.9M | ||
| Q1 25 | $807.3M | $524.2M | ||
| Q4 24 | $885.1M | $551.9M | ||
| Q3 24 | $901.9M | $553.9M | ||
| Q2 24 | $904.5M | $527.9M | ||
| Q1 24 | $831.9M | $499.2M |
负债/权益比
APLS
DAKT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.35× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-14.2M | $16.5M |
| 自由现金流经营现金流 - 资本支出 | $-14.3M | $14.0M |
| 自由现金流率自由现金流/营收 | -7.1% | 6.1% |
| 资本支出强度资本支出/营收 | 0.1% | 1.1% |
| 现金转化率经营现金流/净利润 | — | 0.94× |
| 过去12个月自由现金流最近4个季度 | $45.0M | $61.7M |
8季度趋势,按日历期对齐
经营现金流
APLS
DAKT
| Q4 25 | $-14.2M | $16.5M | ||
| Q3 25 | $108.5M | $26.1M | ||
| Q2 25 | $4.4M | $22.9M | ||
| Q1 25 | $-53.4M | $12.0M | ||
| Q4 24 | $19.4M | $43.3M | ||
| Q3 24 | $34.1M | $19.5M | ||
| Q2 24 | $-8.3M | $9.5M | ||
| Q1 24 | $-133.0M | $9.5M |
自由现金流
APLS
DAKT
| Q4 25 | $-14.3M | $14.0M | ||
| Q3 25 | $108.3M | $21.8M | ||
| Q2 25 | $4.4M | $18.0M | ||
| Q1 25 | $-53.4M | $7.8M | ||
| Q4 24 | $19.3M | $38.0M | ||
| Q3 24 | — | $14.4M | ||
| Q2 24 | $-8.4M | $6.1M | ||
| Q1 24 | $-133.3M | $5.1M |
自由现金流率
APLS
DAKT
| Q4 25 | -7.1% | 6.1% | ||
| Q3 25 | 23.6% | 10.0% | ||
| Q2 25 | 2.5% | 10.5% | ||
| Q1 25 | -32.0% | 5.2% | ||
| Q4 24 | 9.1% | 18.2% | ||
| Q3 24 | — | 6.4% | ||
| Q2 24 | -4.2% | 2.8% | ||
| Q1 24 | -77.3% | 3.0% |
资本支出强度
APLS
DAKT
| Q4 25 | 0.1% | 1.1% | ||
| Q3 25 | 0.0% | 2.0% | ||
| Q2 25 | 0.0% | 2.8% | ||
| Q1 25 | 0.0% | 2.8% | ||
| Q4 24 | 0.0% | 2.6% | ||
| Q3 24 | 0.0% | 2.2% | ||
| Q2 24 | 0.0% | 1.6% | ||
| Q1 24 | 0.2% | 2.6% |
现金转化率
APLS
DAKT
| Q4 25 | — | 0.94× | ||
| Q3 25 | 0.50× | 1.58× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 2.02× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 3.75× | ||
| Q1 24 | — | 0.88× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APLS
| Syfovre | $155.2M | 78% |
| Empaveli Pegcetacoplan | $35.1M | 18% |
| Licensing And Other Revenue | $9.6M | 5% |
DAKT
| Live Events Segment | $81.5M | 36% |
| Transferred At Point In Time | $41.9M | 18% |
| Limited Configuration | $39.2M | 17% |
| Other | $30.6M | 13% |
| Transportation Segment | $21.3M | 9% |
| Transferred Over Time | $8.8M | 4% |
| Unique Configuration | $6.0M | 3% |